Novartis to buy pharmaceutical group AAA for US$3.9b
Zurich
NOVARTIS is buying French-based Advanced Accelerator Applications (AAA) for US$3.9 billion, giving the Swiss drugmaker a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Steve Jobs.
The cash offer of US$41 per ordinary share and US$82 per American depositary share represents a 47 per cent premium to AAA's price before media reports on Sept 27 that Novartis was interested. The ADS closed on Friday at US$7…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Unilever's India quarterly profit disappoints
US: Wall St opens higher on tech boost, upbeat earnings
GM CEO Barra compensation fell 4% in 2023 to US$27.8 million
Prada’s sales up 16% in first quarter as Miu Miu shines
Boeing reports first revenue drop in 7 quarters as deliveries decline
OUE Reit Q1 NPI rises 6.9% to S$60.5 million